CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 205 enrolled
Drug / intervention
Dexamethasone +1 moredrug
Likely dose
Dexamethasone 10 mg IVAI-extracted
Key inclusion· 1
  • Migraine with or without aura; probable migraine without aura
Key exclusion· 2
  • Secondary headache
  • Allergy, contraindication or intolerance to study medication

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00122278
NCT00122278Phase 3Completed

Parenteral Corticosteroids as Adjuvant Therapy for Migraine Headaches

Montefiore Medical Center·interventional·Posted Jul 22, 2005·Updated Nov 13, 2018

In Brief

A Phase 3 clinical trial evaluating Dexamethasone and Placebo for Migraine. Completed, enrolled 205 participants across 3 sites.

Detailed Summary

Migraines are a specific type of headache that frequently recur and are very painful. Although there are many medications that are effective against migraines, none of these medications cure 100% of migraines. Another problem with migraines is that although many times they get better after intravenous (IV) treatment in the emergency room (ER), about 1/3 of the time migraines recur the next day. The purpose of this research project is to see if adding a medication called dexamethasone to standard ER therapy will help patients get better quicker and stay pain-free more often than if they receive placebo.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMigraine
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJul 22, 2005
Enrollment StartJul 1, 2005
Primary CompletionAug 1, 2006
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 20.9 years ago

Interventions

Dexamethasonedrug

Dexamethasone 10mg IV

Placeboother

Placebo Dexamethasone 10mg IV